UniProt ID | SAMP_HUMAN | |
---|---|---|
UniProt AC | P02743 | |
Protein Name | Serum amyloid P-component | |
Gene Name | APCS | |
Organism | Homo sapiens (Human). | |
Sequence Length | 223 | |
Subcellular Localization | Secreted. | |
Protein Description | Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells. May also function as a calcium-dependent lectin.. | |
Protein Sequence | MNKPLLWISVLTSLLEAFAHTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNELLVYKERVGEYSLYIGRHKVTSKVIEKFPAPVHICVSWESSSGIAEFWINGTPLVKKGLRQGYFVEAQPKIVLGQEQDSYGGKFDRSQSFVGEIGDLYMWDSVLPPENILSAYQGTPLPANILDWQALNYEIRGYVIIKPLVWV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNKPLLWI -------CCCCHHHH | 15.24 | - | |
12 | Phosphorylation | LLWISVLTSLLEAFA HHHHHHHHHHHHHHH | 18.38 | 29759185 | |
13 | Phosphorylation | LWISVLTSLLEAFAH HHHHHHHHHHHHHHC | 27.13 | 19413330 | |
21 | Phosphorylation | LLEAFAHTDLSGKVF HHHHHHCCCCCCCEE | 34.89 | 19413330 | |
51 | N-linked_Glycosylation | PLEKPLQNFTLCFRA CCCCCCCCCEEEEEH | 39.28 | 4055725 | |
51 | N-linked_Glycosylation | PLEKPLQNFTLCFRA CCCCCCCCCEEEEEH | 39.28 | 4055725 | |
59 | Phosphorylation | FTLCFRAYSDLSRAY CEEEEEHHHHHHHHH | 9.84 | - | |
63 | Phosphorylation | FRAYSDLSRAYSLFS EEHHHHHHHHHHHHC | 21.61 | 30622161 | |
84 | Acetylation | DNELLVYKERVGEYS CCEEEEEEEEEEEEE | 31.40 | 27178108 | |
142 | Phosphorylation | KKGLRQGYFVEAQPK CCCCCCCCEEEECCE | 8.98 | - | |
195 | O-linked_Glycosylation | ILSAYQGTPLPANIL HHHHHCCCCCCCCCC | 13.21 | OGP | |
218 | Acetylation | IRGYVIIKPLVWV-- EEEEEEEEEEECC-- | 22.60 | 27178108 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SAMP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SAMP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SAMP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SAMP_HUMAN | APCS | physical | 8114934 | |
FCG3A_HUMAN | FCGR3A | physical | 11359830 | |
FCGR1_HUMAN | FCGR1A | physical | 11359830 | |
FCG3B_HUMAN | FCGR3B | physical | 11359830 | |
HES1_HUMAN | HES1 | physical | 21900206 | |
AATM_HUMAN | GOT2 | physical | 21900206 | |
GLPK_HUMAN | GK | physical | 21988832 | |
CSN5_HUMAN | COPS5 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-12; SER-13 AND THR-21, AND MASS SPECTROMETRY. | |
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-12; SER-13 AND THR-21, AND MASS SPECTROMETRY. |